FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4027911000001101: Combivir tablets (GlaxoSmithKline) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17772301000001113 Combivir tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
57431501000001113 Combivir 150mg/300mg tablets (ViiV Healthcare UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Combivir tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Is a Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has active ingredient Lamivudine false Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has active ingredient Zidovudine false Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Is a Combivir true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has specific active ingredient Zidovudine true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has specific active ingredient Lamivudine true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Combivir tablets (GlaxoSmithKline) 60 tablet 6 x 10 tablets Is pack of False Combivir tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) 60 tablet 6 x 10 tablets Has AMP True Combivir tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start